Form 4: SelectQuote Executive Boulware Receives Stock Grants

Sentiment:

SEC Form 4 Filing


Daniel Allen Boulware, General Counsel and Secretary of SelectQuote, Inc., reports the acquisition of restricted stock units and price-vested restricted stock units.

Summary

  • Daniel Allen Boulware, General Counsel and Secretary of SelectQuote, Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On October 28, 2024, Boulware was granted 135,783 restricted stock units (RSUs) and 135,783 price-vested restricted stock units (PVUs) under the company's 2020 Omnibus Incentive Plan.
  • The RSUs vest ratably in three annual installments starting August 1, 2025, contingent upon continued employment.
  • The PVUs are also eligible to vest in three ratable annual installments commencing August 1, 2025, subject to continued employment.
  • Vesting of the PVUs is further contingent on SelectQuote's common stock achieving 60-day average closing prices exceeding $3.13, $6.00, and $9.00 during a five-year performance period.
  • Following the reported transactions, Boulware directly owns 135,783 RSUs and 135,783 PVUs.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of executive compensation. It is neutral in tone and does not contain any information that would significantly impact investor sentiment positively or negatively.

Positives

  • The grant of RSUs and PVUs aligns Boulware's interests with those of the shareholders, incentivizing him to improve the company's performance and stock price.
  • The vesting schedule encourages long-term commitment from Boulware, as continued employment is required for the RSUs and PVUs to vest.

Risks

  • The vesting of PVUs is dependent on the company's stock price reaching certain levels, which may not be achieved within the five-year performance period.
  • If Boulware leaves the company before the vesting dates, he will forfeit the unvested RSUs and PVUs.

Future Outlook

The vesting of the PVUs is contingent on the company's stock price performance over the next five years.

Industry Context

Equity grants are a common practice in publicly traded companies to incentivize executives and align their interests with shareholders. The specific terms of the grants, such as vesting schedules and performance conditions, vary depending on the company's compensation philosophy and industry practices.

Comparison to Industry Standards

  • Stock grants are a common form of executive compensation, used by companies like eHealth, Inc. and GoHealth to incentivize performance.
  • The vesting schedules and performance metrics attached to these grants are often tailored to the specific goals and challenges of the company.
  • The use of price-vested units is less common than time-based vesting, but it directly ties executive compensation to shareholder value creation.

Stakeholder Impact

  • The grant of RSUs and PVUs could potentially align management's interests with shareholders, encouraging decisions that increase shareholder value.
  • Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
10/28/2024Date of transaction: Grant of restricted stock units and price-vested restricted stock units.
08/01/2025Commencement date for ratable vesting of RSUs and PVUs in three annual installments.
10/28/2034Expiration date for the restricted stock units and price-vested restricted stock units.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.